SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort

Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, Erika Zecca, Erica Matino, Micol Cittone, Eleonora Rizzi, Giuseppe Francesco Casciaro, Davide D’Onghia, Donato Colangelo, Rosalba Minisini, Mattia Bellan, Luigi Mario Castello, Annalisa Chiocchetti, Mario Pirisi, Cristina Rigamonti, Daniele Lilleri, Federica Zavaglio, Federica Bergami, Daniele SolaPier Paolo Sainaghi

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Fingerprint

Entra nei temi di ricerca di 'SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort'. Insieme formano una fingerprint unica.

Ordina per
Peso
Alfabetico

SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort

Fingerprint

Keyphrases

Medicine and Dentistry

Immunology and Microbiology